A detailed history of Comerica Bank transactions in Natera, Inc. stock. As of the latest transaction made, Comerica Bank holds 11,342 shares of NTRA stock, worth $1.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,342
Previous 13,236 14.31%
Holding current value
$1.9 Million
Previous $1.43 Million 0.56%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $185,138 - $245,594
-1,894 Reduced 14.31%
11,342 $1.44 Million
Q2 2024

Aug 15, 2024

SELL
$85.28 - $112.6 $139,006 - $183,538
-1,630 Reduced 10.96%
13,236 $1.43 Million
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $722,480 - $1.13 Million
12,202 Added 458.03%
14,866 $1.36 Million
Q4 2023

Feb 14, 2024

SELL
$37.55 - $62.64 $1,990 - $3,319
-53 Reduced 1.95%
2,664 $166,000
Q3 2023

Nov 21, 2023

SELL
$43.4 - $62.52 $108,326 - $156,049
-2,496 Reduced 47.88%
2,717 $120,000
Q2 2023

Aug 22, 2023

BUY
$47.08 - $55.16 $245,428 - $287,549
5,213 New
5,213 $6,000
Q1 2022

Apr 27, 2022

SELL
$30.32 - $91.33 $325,576 - $980,701
-10,738 Closed
0 $0
Q4 2021

Feb 18, 2022

BUY
$86.26 - $119.0 $18,373 - $25,347
213 Added 2.02%
10,738 $1 Million
Q3 2021

Nov 22, 2021

SELL
$100.17 - $126.36 $276,769 - $349,132
-2,763 Reduced 20.79%
10,525 $1.17 Million
Q2 2021

Aug 26, 2021

SELL
$86.05 - $119.72 $229,753 - $319,652
-2,670 Reduced 16.73%
13,288 $1.51 Million
Q1 2021

Apr 28, 2021

BUY
$91.47 - $124.36 $5,213 - $7,088
57 Added 0.36%
15,958 $1.62 Million
Q4 2020

Jan 28, 2021

SELL
$66.66 - $111.74 $36,596 - $61,345
-549 Reduced 3.34%
15,901 $1.58 Million
Q3 2020

Oct 30, 2020

SELL
$45.89 - $72.67 $9,178 - $14,534
-200 Reduced 1.2%
16,450 $1.19 Million
Q2 2020

Jul 31, 2020

BUY
$26.36 - $49.86 $438,894 - $830,169
16,650 New
16,650 $830,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.